세계의 페닐레프린약 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Phenylephrine Drugs Market is presumed to reach the market size of nearly USD 40.61 Billion by 2032 from USD 22.05 Billion in 2023 with a CAGR of 7.02% under the study period 2024-2032.

Phenylephrine drugs are a class of medications employed to alleviate nasal congestion and sinus pressure linked with conditions like the common cold, allergies, and sinusitis. They constrict blood vessels in the nasal passages, reducing swelling and congestion and facilitating easier breathing. These drugs are available in various formulations, including nasal sprays, oral tablets, and eye drops, providing flexibility in administration and dosage. Though generally regarded as safe and effective when used according to instructions, these drugs may cause elevated blood pressure, rapid heartbeat, and headache in some individuals. They are commonly found in over-the-counter cold and allergy medications, relieving nasal congestion and related symptoms.

MARKET DYNAMICS

The increasing prevalence of nasal congestion, sinusitis, and allergic rhinitis worldwide, coupled with the rising incidence of colds, flu, and respiratory infections, drives demand for phenylephrine-based decongestants as over-the-counter and prescription medications. As individuals seek relief from nasal congestion and related symptoms, phenylephrine drugs offer rapid and effective relief by narrowing nasal passages blood vessels and reducing swelling and congestion. Additionally, advancements in drug formulations, delivery systems, and combination therapies drive innovation in phenylephrine drugs, enabling the development of extended-release formulations, multi-symptom relief products, and pediatric-friendly dosage forms to meet diverse patient needs.

Furthermore, the expanding applications of phenylephrine drugs in ophthalmic solutions, oral medications, and injectable formulations for cardiovascular support are driving market growth and diversification. Moreover, the increasing focus on self-care, wellness, and preventive healthcare drives demand for over-the-counter phenylephrine products as consumers seek convenient and accessible solutions for managing cold and allergy symptoms at home. However, the availability of alternative decongestant medications and the emergence of non-pharmacological treatments for nasal congestion may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Phenylephrine Drugs. The growth and trends of Phenylephrine Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Phenylephrine Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Tablets
• Syrups
• Eye Drops
• Other

By Route Of Administration

• Oral
• Parenteral
• Other

By Indication

• Cold
• Nasal Decongestion
• Allergic Reaction
• Eye Disease
• Other

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Phenylephrine Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Phenylephrine Drugs market include Novartis AG, Perrigo Company PLC, Johnson & Johnson Consumer Inc. (Kenvue Inc.), Proctor & Gamble Co., Pfizer Inc., Foundation Consumer Brands LLC, Mylan N.V., Torrent Pharmaceuticals Inc., GlaxoSmithKline PLC, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PHENYLEPHRINE DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Indication
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product Type
• 5.4. Tablets Historic and Forecast Sales By Regions
• 5.5. Syrups Historic and Forecast Sales By Regions
• 5.6. Eye Drops Historic and Forecast Sales By Regions
• 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 6.1. Overview By Route Of Administration
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Route Of Administration
• 6.4. Oral Historic and Forecast Sales By Regions
• 6.5. Parenteral Historic and Forecast Sales By Regions
• 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY INDICATION

• 7.1. Overview By Indication
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Indication
• 7.4. Cold Historic and Forecast Sales By Regions
• 7.5. Nasal Decongestion Historic and Forecast Sales By Regions
• 7.6. Allergic Reaction Historic and Forecast Sales By Regions
• 7.7. Eye Disease Historic and Forecast Sales By Regions
• 7.8. Other Historic and Forecast Sales By Regions

8. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data
• 8.3. Analysis By Distribution Channel
• 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
• 8.5. Drug Stores & Retail Pharmacies Historic and Forecast Sales By Regions
• 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PHENYLEPHRINE DRUGS COMPANIES

• 10.1. Phenylephrine Drugs Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF PHENYLEPHRINE DRUGS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Novartis AG
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Perrigo Company PLC
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Johnson & Johnson Consumer Inc. (Kenvue Inc.)
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Proctor & Gamble Co.
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Pfizer Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Foundation Consumer Brands LLC
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Mylan N.V.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Torrent Pharmaceuticals Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. GlaxoSmithKline PLC
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Bayer AG
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies